Skip to main content
Billions Co.,Ltd. logo

Billions Co.,Ltd. — Investor Relations & Filings

Ticker · 044480 ISIN · KR7044480002 KO Wholesale and retail trade
Open in API
Filings indexed 590 across all filing types
Latest filing 2020-08-21 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 044480

About Billions Co.,Ltd.

http://www.unidus.co.kr

Billions Co.,Ltd. is a company with diversified operations in the entertainment and manufacturing sectors. In the entertainment field, the company is involved in artist management and the production of dramas and movies. Concurrently, its manufacturing division produces and markets latex medical products, including prophylactics, surgical gloves, and finger cots. The company has previously operated under different names, including Blade Entertainment Co Ltd and Unidus Corporation, reflecting its distinct business segments.

Recent filings

Filing Released Lang Actions
전환가액의조정(제2회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the 'Adjustment of Conversion Price' (전환가액의 조정) for convertible bonds issued by Gyeongnam Bio Pharma. It details the change in conversion price due to market price decline (refixing), the impact on the number of convertible shares, and the calculation methodology. This falls under capital structure changes related to debt instruments, which is best classified as a Capital/Financing Update.
2020-08-21 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제2회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Gyeongnam Bio Pharma regarding the early acquisition (buyback) of convertible bonds (2nd series) before maturity. It details the bond type, acquisition amount, acquisition date, and the reason for the buyback (early redemption request). This falls under capital structure changes and financing updates, specifically related to debt instruments, which is best classified as a Capital/Financing Update (CAP).
2020-08-21 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a South Korean company (Gyeongnam Bio Pharma) regarding the acquisition of convertible bonds before maturity. This type of corporate action, involving changes to the company's debt structure and capital obligations, falls under the 'Capital/Financing Update' category as it details the early redemption/acquisition of issued convertible bonds.
2020-08-20 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Kyung Nam Biopharma' for the period ending June 30, 2020. It contains detailed financial statements, business descriptions, capital structure, and management information. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. H1 2020
2020-08-14 Korean
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Disclaimer of Opinion' (의견거절) on the company's semi-annual financial statements. It details the audit findings, financial data, and the reason for the disclaimer. While it references a semi-annual report, it is a specific regulatory disclosure regarding audit status and financial health (capital impairment/audit opinion), which falls under the category of Audit Report/Information (AR) as it pertains to the results of an audit process. H1 2020
2020-08-14 Korean
주권매매거래정지(관리종목지정사유발생)
Delisting Announcement Classification · 100% confidence The document is a short, formal notice regarding the suspension of stock trading for a specific company (Kyungnam Bio Pharma) due to the designation of an administrative stock status. It cites specific exchange regulations (KOSDAQ listing rules) and provides the effective date and duration of the suspension. Since this is a regulatory announcement regarding trading status and does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2020-08-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.